Please wait a minute...

中国生物工程杂志

CHINA BIOTECHNOLOGY
中国生物工程杂志  2010, Vol. 30 Issue (04): 20-25    
技术与方法     
Ang2、Tie2基因的RNA干扰及其在体外抑制血管生成的作用
王彪1**,刘照亮1,林菊丽1,单秀英1,王美水1,张声1,鲁开化2
1.福建医科大学附属第一医院 福州 350005
2.第四军医大学西京医院整形外科研究所 西安 710043
Ang2,Tie2 RNA Interference and the Function of Them on Inhibiting Angiogenesis in vitro
WANG Biao1,LIU Zhao-liang1,LIN Ju-li1,SHAN Xiu-ying1,WANG Mei-shui1,ZHANG Sheng1,LU Kai-hua2
1.The First Affiliated Hospital, Fujian Medical University, Fuzhou 350005,China
2.The Centre of Plastic Surgery,The Fourth Military Medical University, Xi’an 710043,China
 全文: PDF(687 KB)   HTML
摘要:

目的:探讨应用RNA干扰(RNA interference,RNAi)技术沉默Ang2、Tie2基因及其在体外抑制血管生成的研究,为将来进一步进行抑制肿瘤血管生成的动物实验研究奠定基础,为肿瘤的基因治疗提供实验依据。方法:用pSilencer 1.0-U6-Ang2/Tie2-siRNA重组质粒转染人脐静脉内皮细胞(HUVECs),采用RTPCR检测各组HUVECs Ang2、Tie2的mRNA表达状况。应用体外血管生成的三维培养模型研究转染后的HUVECs在体外形成血管样结构的情况。结果:pSilencer 1.0-U6-Ang2/Tie2-siRNA重组质粒转染HUVECs后,RT-PCR检测结果显示: Ang2、Tie2基因mRNA的表达水平均受到明显抑制(P<0.05),并且siRNA的2条重组质粒之间均无明显差别(P>0.05)。转染后的HUVECs在体外三维培养模型中血管样结构形成的数量和长度均明显减少(P<0.05),表明血管生成受到明显抑制。结论:Ang2-siRNA、Tie2-siRNA能够抑制HUVECs中Ang2和Tie2的mRNA表达,从而在体外抑制血管生成。

关键词: RNAi促血管生成素家族及其受体血管生成内皮细胞体外三维培养    
Abstract:

Objective: The expression of Ang2 and Tie2 is silenced by RNA interference in order to inhibit the angiogenesis in vitro. The study will supply the theory basis to the further animal research on the inhibition of tumor angiogenesis in vivo and provide the experimental evidence for tumor gene therapy in future. Methods: Using pSilencer 1.0-U6-Ang2/Tie2-siRNA recombinant plasmid to transfect into human umbilical vein endothelial cells (HUVECs), using RT-PCR to analyze the mRNA expression levels of Ang2 and Tie2 in HUVECs of each groups respectively. And the formation of vascular-like structure in HUVECs,transfected by the plasmids ,was studied in vitro by three-dimensional culture. Results: After the recombinant plasmids of pSilencer1.0-U6-Ang2/Tie2-siRNA transfected HUVECs,the mRNA expression levels of Ang2 、Tie2 in HUVECs were average obviously suppressed by RT-PCR(P<0.05),and there is no significant difference on the expression levels(P>0.05)between the two plasmids of each siRNA . There is a significant decrease on the quantity and length of vascular-like structure in HUVECs,transfected with the recombinant plasmids by three-dimensional culture model in vitro,(P<0.05).It proves that angiogenesis has been inhibited significantly in vitro. Conclusions:Ang2-siRNA、Tie2-siRNA can inhibit the mRNA expression of Ang2、Tie2 in HUVECs, and inhibit angiogenesis in the model of three-dimensional culture in vitro.

Key words: RNA interfierence    Angiopoietin family and receptors    Angiogenesis    in vitro three-dimensional endothelial cell culture
收稿日期: 2009-12-23 出版日期: 2010-04-29
基金资助:

卫生部科学研究基金—福建省卫生教育联合攻关计划(WKJ2008-2-51)、福建省自然科学基金计划(2007J0269)、福建省教育厅科技项目(JB08088)资助项目

通讯作者: 王彪     E-mail: wangbiao123@tom.com
服务  
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章  
王彪
刘照亮
林菊丽
单秀英
王美水
张声
鲁开化

引用本文:

王彪 刘照亮 林菊丽 单秀英 王美水 张声 鲁开化. Ang2、Tie2基因的RNA干扰及其在体外抑制血管生成的作用[J]. 中国生物工程杂志, 2010, 30(04): 20-25.

链接本文:

https://manu60.magtech.com.cn/biotech/CN/Y2010/V30/I04/20

[1] Rana Tariq M. Illuminating the silence: understanding the structure and function of small RNAs. Nat Rev Mol Cell Biol,2007,8:2336. 
[2] McManus M T,Sharp P A.Gene silencing in mammals by small interfering RNAs.Nature,2002,3(10):737747. 
[3] Nykanen A, Haley B, Zamore P D. ATP requirements and small interfering RNA structure in the RNA interference pathway. Cell, 2001,107:309321. 
[4] Hannon Gregory J,Rossi John J.Unlocking the potential of the human genome with RNA interference.Nature,2004,431:371378. 
[5] Malsonpierre P C,Suri C.Jones P F,et at.Angiopoietin2.a natural antagonist for tie2 that disrupts in vivo angiogenesis. Science,1997,277(5322):5560. 
[6] George D Y,Samuel D,Nicholas W G,et al.Vascularspecific growth factors and blood vessel formation.Nature,20O0,407:242248. 
[7] Arai F,Hirao A,Ohmura M,et a1.Tie2/Angiopoietin1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche.Cell,2004,118:149161. 
[8] Fiedler U,Augustin H G.Angiopoietins:a link between angiogenesis and inflammation.Trends Immunol,2006,27(12):552558. 
[9] Jonathan Oliner,Hosung Min, Juan Leal, et al. Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin2. Cancer Cell,2004,6(5):507516. 
[10] Rebekah R White,Siqing Shan,Christopher P, et al. Inhibition of rat corneal angiogenesis by a nucleaseresistant RNA aptamer specific for angiopoietin2. PNAS,2003,100:50285033. 
[11] Lin P,Buxton J A,Acheson A,et al.Antiagiogeni gene therapy targeting the endotheliumspecific receptor tyrosine kinase Tie2.Proc Natl Acad Sci USA,1998,95:88298834. 
[12] 王彪,单秀英,林菊丽,等. 促血管生成素2及其受体Tie2基因RNA干扰表达载体的构建与鉴定.医学综述,2009,15(21):34983501. Wang B, Shan X Y, Lin J L, et al. Medical Recapitulate,2009,15(21):34983501. 
[13] 林菊丽,王彪,黄祖根,等. 体外血管生成三维培养模型的构建. 福建医科大学学报,2009,43(01)4952 Lin J L, Wang B, Huang Z G, et al.Journal of Fujian Medical University,2009,43(01)4952. 
[14] Paddison P J, Hannon G J. siRNA and shRNAs: skeleton keys to the human genome. Curr Opin Mol Ther,2003,5(3):217224. 
[15] Zhang H, Fabrice A K, Lukasz J, et al. Single processing center models for human Dicer and bacterial RNase III.Cell, 2004,118: 5768. 
[16] Saharinen P, Kerkela K, Ekman N, et al.Multiple angiopoietin recombinant proteins activate the Tie1 receptor tyrosine kinase and promote its interaction with Tie2.J Cell Biol,2005,169:239240. 
[17] Xia X G, Zhou H, Ding H, et al. An enhanced U6 promoter for synthesis of short hairpin RNA. Nucleic Acids Res, 2003,31(17):100. 
[18] Dykxhoorn D M, Novina C D, Sharp P A. Killing the messenger: short RNAs that silence gene expression. Nat Rev Mol Cell Biol,2003,4(6):457467.

[1] 曹荣月, 俞敏霞, 张昕黎, 李曼曼, 苗梓韬, 金亮. VEGFⅡ/GRP融合蛋白的构建、表达、纯化及其抗小鼠RM-1前列腺癌的作用研究[J]. 中国生物工程杂志, 2016, 36(8): 9-15.
[2] 任琴, 郭志鸿, 王亚军, 谢忠奎, 王若愚. RNA干扰及其在增强作物抵抗有害真核生物研究中的应用[J]. 中国生物工程杂志, 2015, 35(6): 80-89.
[3] 薛玉文, 李铁军, 周家名, 陈莉. 多靶向RNA干扰技术在基因治疗中的应用与前景[J]. 中国生物工程杂志, 2015, 35(1): 75-81.
[4] 李玉强, 朱志图, 王巍, 李谌, 徐娜, 王钰, 李男, 孙宏治. RNA干扰NUP88基因对人乳腺癌MCF-7细胞生长及侵袭力的影响[J]. 中国生物工程杂志, 2014, 34(9): 31-39.
[5] 赵晶, 吕慧, 贾依娜古丽·朱玛拜, 孙素荣. 骆驼蓬脂转移蛋白基因真核表达载体的构建及其体内外抗瘤效应的研究[J]. 中国生物工程杂志, 2014, 34(8): 7-13.
[6] 陈悦, 付中平, 李景荣, 殷晓进. 重组蛋白ES-Kringle5的表达、纯化及活性检测[J]. 中国生物工程杂志, 2014, 34(5): 60-65.
[7] 蒋婷婷, 温晓霞, 陈尧. 沉默c2orf68基因对结直肠癌细胞增殖的影响[J]. 中国生物工程杂志, 2014, 34(2): 7-13.
[8] 王鑫, 陈玲, 孙飞, 陆航. RNAi沉默CXCR7对人结肠癌细胞SW620特异性靶向抑制的实验研究[J]. 中国生物工程杂志, 2014, 34(2): 14-20.
[9] 元小宁, 朱运峰. 外泌体(Exosome)及其在肿瘤调控中的作用[J]. 中国生物工程杂志, 2013, 33(8): 111-117.
[10] 赵蕊, 吕静野, 黄海丽, 严启滔. CHD5基因RNAi慢病毒载体的构建及其对结直肠癌细胞生物学功能的影响[J]. 中国生物工程杂志, 2012, 32(05): 7-11.
[11] 丁笠, 王秀云, 齐海迪, 李海鑫, 周雅琼, 陈耀祖, 张娟, 王旻. 抗血管内皮生长因子受体2双价单链抗体的构建表达及其活性研究[J]. 中国生物工程杂志, 2011, 31(8): 1-6.
[12] 刘铁连, 陈佑明, 黄敬, 李华, 杨吉成. Ad-Ang1-IRES-VEGF165腺病毒载体的构建及其促血管形成作用[J]. 中国生物工程杂志, 2011, 31(11): 51-57.
[13] 李培培, 游雷鸣, 罗俊, 鄂魏, 蒋志政, 郅玉宝, 张改平, 王爱萍. 鸡源细胞基因沉默及快速筛选的实用型双标记RNAi载体[J]. 中国生物工程杂志, 2011, 31(11): 81-89.
[14] 陈光辉, 刘预, 孔飞飞, 邱欣欣, 成凤, 匡文斌, 李朴, 涂植光. shRNA靶向干扰COX-2抑制人肝癌裸鼠皮下移植瘤及其血管生成[J]. 中国生物工程杂志, 2011, 31(03): 29-34.
[15] 秦俊文, 谢琪璇, 蔡冬青, 秋山泰身, 井上纯一郎. shRNA慢病毒质粒的构建技巧[J]. 中国生物工程杂志, 2011, 31(03): 124-127.